Moyamoya disease epidemiology and demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Vishnu Vardhan Serla M.B.B.S. [2]
Epidemiology and Demographics
Incidence
In Japan the overall incidence is higher (0.35 per 100,000).[1] It is more common in women than in men, although about a third of those affected are male .[2]
Age
It is a disease that tends to affect children and adults in the third to fourth decades of life. In children it tends to cause strokes or seizures. In adults it tends to cause strokes or bleeding.
Gender
Women frequently experience transient ischemic attacks (TIA), cerebral hemorrhage or no symptoms. They have a higher risk of recurrent stroke and may be experiencing a distinct underlying pathophysiology compared to patients from Japan. Data suggest a potential benefit with surgery if early diagnosis is made.[3]
References
- ↑ Wakai K, Tamakoshi A, Ikezaki K; et al. (1997). “Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey”. Clin Neurol Neurosurg. 99 Suppl 2: S1–5. doi:10.1016/S0303-8467(97)00031-0. PMID 9409395.
- ↑ Kuriyama S, Kusaka Y, Fujimura M; et al. (2008). “Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey”. Stroke. 39 (1): 42–7. doi:10.1161/STROKEAHA.107.490714. PMID 18048855.
- ↑ Hallemeier C, Rich K, Brubb R, Chicoine M, Moran C, Cross D, Zipfel G, Dacey R, Derdeyn (2006). “Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey”. Stroke. 37 (6): 1490–1496. doi:10.1161/01.STR.0000221787.70503.ca. PMID 16645133.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH